Skip to main content
. 2022 Aug 5;10(8):1574. doi: 10.3390/microorganisms10081574

Figure 4.

Figure 4

Body mass (a), waist circumference (b), and body mass index (c) of patients with MS before and after therapy. Notes: HV—healthy volunteers; MS—patients with metabolic syndrome; MS+IC—patients with metabolic syndrome after consumption of indigenous consortium. Results are presented as median (25%; 75%).